The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway
Article in Endocrinology (April 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
Article in Cancer Cell International (May 2023)
Prolactin Receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in Acute Myeloid Leukemia
Preprint in Research Square (May 2022)